phase readout
saveNCT07033182: Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment
COMPLETEDupdated 43m ago
community read0 votes
Sponsor: Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd. Phase: PHASE1. Conditions: Infections Caused by Anaerobic Bacteria, Renal Impairment
view source ↗
comments(0)
5-min edit window · permanent after that